Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - Other
Ratios

Aclaris Therapeutics (ACRS) Leases (2019 - 2020)

Aclaris Therapeutics has reported Leases over the past 2 years, most recently at $435000.0 for Q3 2020.

  • Quarterly results put Leases at $435000.0 for Q3 2020, changed 0.0% from a year ago — trailing twelve months through Sep 2020 was $435000.0 (changed 0.0% YoY), and the annual figure for FY2019 was $435000.0, changed.
  • Leases for Q3 2020 was $435000.0 at Aclaris Therapeutics, roughly flat from $435000.0 in the prior quarter.
  • Over the last five years, Leases for ACRS hit a ceiling of $2.6 million in Q1 2019 and a floor of $435000.0 in Q3 2019.